Literature DB >> 11500300

Effects of antecedent hypoglycemia, hyperinsulinemia, and excess corticosterone on hypoglycemic counterregulation.

K Shum1, K Inouye, O Chan, J Mathoo, D Bilinski, S G Matthews, M Vranic.   

Abstract

This study aimed to differentiate the effects of repeated antecedent hypoglycemia, antecedent marked hyperinsulinemia, and antecedent increases in corticosterone on counterregulation to subsequent hypoglycemia in normal rats. Specifically, we examined whether exposure to hyperinsulinemia or elevated corticosterone per se could impair subsequent counterregulation. Four groups of male Sprague-Dawley rats were used: 1) normal controls (N) had 4 days of sham antecedent treatment; 2) an antecedent hypoglycemia group (AH) had 7 episodes of hyperinsulinemic hypoglycemia over 4 days; 3) an antecedent hyperinsulinemia group (AE) had 7 episodes of hyperinsulinemic euglycemia; and 4) an antecedent corticosterone group (AC) had 7 episodes of intravenous corticosterone to simulate the hypoglycemic corticosterone levels in AH rats. On day 5, hyperinsulinemic euglycemic-hypoglycemic clamps were performed. Epinephrine responses to hypoglycemia were impaired (P < 0.05 vs. N) after antecedent hypoglycemia and hyperinsulinemia. This correlated with diminished (P < 0.05 vs. N) absolute glucose production responses in AH rats and diminished incremental glucose production responses in AE rats. Paradoxically, norepinephrine responses were increased (P < 0.05 vs. N) after antecedent hypoglycemia. Glucagon and corticosterone responses were unaffected by antecedent hypoglycemia and hyperinsulinemia. In AC rats, incremental but not absolute glucose production responses were decreased (P < 0.05 vs. N). However, neuroendocrine counterregulation was unaltered. We conclude that both antecedent hypoglycemia and hyperinsulinemia impair epinephrine and glucose production responses to subsequent hypoglycemia, suggesting that severe recurrent hyperinsulinemia may contribute to the development of hypoglycemia-associated autonomic failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500300     DOI: 10.1152/ajpendo.2001.281.3.E455

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  12 in total

1.  Antecedent hindbrain glucoprivation does not impair the counterregulatory response to hypoglycemia.

Authors:  Nicole M Sanders; Gerald J Taborsky; Charles W Wilkinson; Wendi Daumen; Dianne P Figlewicz
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

2.  Partial blockade of nicotinic acetylcholine receptors improves the counterregulatory response to hypoglycemia in recurrently hypoglycemic rats.

Authors:  Edmund F LaGamma; Necla Kirtok; Owen Chan; Bistra B Nankova
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-12       Impact factor: 4.310

Review 3.  From bedside to bench and back again: research issues in animal models of human disease.

Authors:  Nancy C Tkacs; Hilaire J Thompson
Journal:  Biol Res Nurs       Date:  2006-07       Impact factor: 2.522

4.  Combined corticotropin-releasing hormone and glucocorticoid deficiency does not enhance counterregulatory responses after recurrent hypoglycemia in mice.

Authors:  Lauren Jacobson; Karel Pacák
Journal:  Metabolism       Date:  2005-09       Impact factor: 8.694

5.  Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia.

Authors:  Lauren Jacobson; Tasneem Ansari; Jessica Potts; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

6.  Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice.

Authors:  Lauren Jacobson; Tasneem Ansari; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04       Impact factor: 4.310

7.  Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia.

Authors:  Owen Chan; Haiying Cheng; Raimund Herzog; Daniel Czyzyk; Wanling Zhu; Ajin Wang; Rory J McCrimmon; Margretta R Seashore; Robert S Sherwin
Journal:  Diabetes       Date:  2008-03-28       Impact factor: 9.461

8.  Impact of recurring intermediate insulin-induced hypoglycemia on hypothalamic paraventricular corticotropin-releasing hormone, oxytocin, vasopressin and glucokinase gene profiles: role of type II glucocorticoid receptors.

Authors:  Karen P Briski; Ajay Y Kale; Kamlesh V Vavaiya
Journal:  Exp Brain Res       Date:  2009-05-06       Impact factor: 1.972

9.  Direct effects of recurrent hypoglycaemia on adrenal catecholamine release.

Authors:  Branly O Orban; Vanessa H Routh; Barry E Levin; Joshua R Berlin
Journal:  Diab Vasc Dis Res       Date:  2014-09-29       Impact factor: 3.291

10.  Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats.

Authors:  Emily G Hoffman; Mahsa Jahangiriesmaili; Erin R Mandel; Caylee Greenberg; Julian Aiken; Ninoschka C D'Souza; Aoibhe Pasieka; Trevor Teich; Owen Chan; Richard Liggins; Michael C Riddell
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.